Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases
Clinical trial NCT06248606 · RECRUITING
Trial details
- NCT number
- NCT06248606
- Sponsor
- Ryan Gentzler, MD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-06
- Primary completion
- 2027-02-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.